Friday, 4 September 2026European Markets

ELKEM And CORBION Have A High Dividend Yield And Return On Equity In The Specialty Chemicals Industry.

Loading stream...

(VIANEWS) - ELKEM (ELK.OL) is among this list of stock assets with the highest dividend rate and return on equity on the Specialty Chemicals industry.

Financial Asset Price Forward Dividend Yield Return on Equity
ELKEM (ELK.OL) kr19.69 25.91% 19.37%
CORBION (CRBN.AS) €20.56 3.16% 11.55%

Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. ELKEM (ELK.OL)

25.91% Forward Dividend Yield and 19.37% Return On Equity

Elkem ASA engages in the provision of advanced material solutions worldwide. It operates through three segments: Silicones, Silicon Products, and Carbon Solutions. The company offers silicones polymers, including silicone oils, compounds, emulsions, grease, and resins, as well as chlorosilanes, heat cured rubber silicone, liquid silicone rubber, and RTV-1 and RTV-2 silicones. It also provides silicon-based materials comprising silicon, silicon powder/micronized silicon, silica fume/ micro-silica, ferrosilicon, and grain refiners. In addition, the company offers foundry alloys, such as preconditioners, recarburizers, conditioners, nodularizers, inserts, and inoculants; and carbon-based materials comprising carbon electrodes, furnace tapping materials, electrode paste, ramming paste, prebaked electrodes, and furnace lining materials, as well as polymer additives, and oilfield and refractories specialty products. It offers its products to electronics, aerospace, healthcare, personal care, packaging, airbag coating, chemicals, aluminium, electronics, automotive, specialty steel, solar, construction, refractories, oil and gas, ferroalloys, silicon, and aluminium industries. The company was founded in 1904 and is headquartered in Oslo, Norway. Elkem ASA operates as a subsidiary of Bluestar Elkem International Co., Ltd. S.A.

Earnings Per Share

As for profitability, ELKEM has a trailing twelve months EPS of kr-2.08.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 19.37%.

More news about ELKEM.

2. CORBION (CRBN.AS)

3.16% Forward Dividend Yield and 11.55% Return On Equity

Corbion N.V. provides lactic acid and lactic acid derivatives, other ferment, functional enzyme blends, minerals, vitamins, and algae ingredients worldwide. It offers ingredient solutions for the food, home and personal care, animal nutrition, supplements, pharmaceuticals, medical devices, and bioplastics markets. The company markets its products through a network of sales offices and distributors. The company was formerly known as CSM N.V. and changed its name to Corbion N.V. in October 2013. Corbion N.V. was incorporated in 1919 and is headquartered in Amsterdam, the Netherlands.

Earnings Per Share

As for profitability, CORBION has a trailing twelve months EPS of €1.22.

PE Ratio

CORBION has a trailing twelve months price to earnings ratio of 16.85. Meaning, the purchaser of the share is investing €16.85 for every euro of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.55%.

Volatility

CORBION's last week, last month's, and last quarter's current intraday variation average was 2.11%, 0.17%, and 1.49%.

CORBION's highest amplitude of average volatility was 2.86% (last week), 1.19% (last month), and 1.49% (last quarter).

Moving Average

CORBION's worth is higher than its 50-day moving average of €19.28 and above its 200-day moving average of €18.94.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, CORBION's stock is considered to be oversold (<=20).

More news about CORBION.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Funding Surge: Capital Floods Fintech, Foundation Models, and Autonomous Systems
A concentrated burst of AI-linked funding on 2026-08-28 pushed well over $1.5B into companies spanning fraud/identity fintech (Socure, which also acquired Fravity), foundation models (Stability AI), AI agents and enterprise tooling (Instinct, Generalist AI, Emerald AI, Owner), and AI-adjacent autonomous/aerospace ventures (Gatik, Regent Craft). The breadth and simultaneity of these rounds signal that investor appetite for AI is not concentrated in a single vertical but is broadening into applied and infrastructure-adjacent domains, with consolidation (Socure-Fravity) beginning alongside fresh capital formation.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,269 source documents archived
Query this data → isubstrate.com